• 1
    Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind C. Digestive system tumors. In: I.U.A.C. UICC ed. Prognostic factors in cancer, 2nd ed. New York: Wiley-Liss, 2001. 235347.
  • 2
    Duffy MJ. Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 2001;47: 62430.
  • 3
    Carriquiry LA, Pineyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum 1999;42: 9219.
  • 4
    Nakayama T, Watanabe M, Teramoto T, Kitajima M. CA19-9 as a predictor of recurrence in patients with colorectal cancer. J Surg Oncol 1997;66: 23843.
  • 5
    Lindmark G, Kressner U, Bergstrom R, Glimelius B. Limited clinical significance of the serum tumour marker CA 72-4 in colorectal cancer. Anticancer Res 1996;16: 8958.
  • 6
    Carpelan-Holmström M, Haglund C, Lundin J, Alfthan H, Stenman UH, Roberts PJ. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer. Br J Cancer 1996;74: 9259.
  • 7
    Filella X, Molina R, Grau JJ, Pique JM, Garcia-Valdecasas JC, Astudillo E, Biete A, Bordas JM, Novell A, Campo E, Ballesta AM. Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg 1992;216: 559.
  • 8
    Marcillac I, Troalen F, Bidart JM, Ghillani P, Ribrag V, Escudier B, Malassagne B, Droz JP, Lhomme C, Rougier P, Duvillard P, Prade M, et al. Free human chorionic gonadotropin β subunit in gonadal and nongonadal neoplasms. Cancer Res 1992;52: 39017.
  • 9
    Louhimo J, Nordling S, Alfthan H, Von Boguslawski K, Stenman UH, Haglund C. Specific staining of human chorionic gonadotropin β in benign and malignant gastrointestinal tissues with monoclonal antibodies. Histopathology 2001;38: 41824.
  • 10
    Louhimo J, Finne P, Alfthan H, Stenman UH, Haglund C. Combination of HCGβ, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res 2002;22: 175964.
  • 11
    Lundin M, Nordling S, Lundin J, Alfthan H, Stenman UH, Haglund C. Tissue expression of human chorionic gonadotropin β predicts outcome in colorectal cancer: a comparison with serum expression. Int J Cancer 2001;95: 1822.
  • 12
    Davis NC, Evans EB, Cohen JR, Theile DE. Staging of colorectal cancer. The Australian clinico-pathological staging (ACPS) system compared with Dukes' system. Dis Colon Rectum 1984;27: 70713.
  • 13
    Alfthan H, Schröder J, Fraser R, Koskimies A, Halila H, Stenman UH. Choriogonadotropin and its β subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem 1988;34: 175862.
  • 14
    Alfthan H, Haglund C, Dabek J, Stenman UH. Concentrations of human choriogonadotropin, its β-subunit, and the core fragment of the β-subunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38: 19817.
  • 15
    Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata b11 immunological tolerance and adsorption techniques. J Exp Med 1965;121: 43962.
  • 16
    Chapman MA, Buckley D, Henson DB, Armitage NC. Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer 1998;78: 13469.
  • 17
    Kos J, Nielsen HJ, Krasovec M, Christensen IJ, Cimerman N, Stephens RW, Brunner N. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer. Clin Cancer Res 1998;4: 15116.
  • 18
    Webb A, Scott-Mackie P, Cunningham D, Norman A, Andreyev J, O'Brien M, Bensted J. The prognostic value of CEA, βHCG, AFP, CA125, CA19-9 and C-erb B-2, βHCG immunohistochemistry in advanced colorectal cancer. Ann Oncol 1995;6: 5817.